Dimethyl Fumarate Alleviates NLRP3 Inflammasome Activation in Microglia and Sickness Behavior in LPS-Challenged Mice

被引:69
作者
Tastan, Bora [1 ,2 ]
Arioz, Burak I. [1 ,2 ]
Tufekci, Kemal Ugur [1 ,3 ]
Tarakcioglu, Emre [1 ,2 ]
Gonul, Ceren Perihan [1 ,2 ]
Genc, Kursad [4 ]
Genc, Sermin [1 ,4 ]
机构
[1] Izmir Biomed & Genome Ctr, Genc Lab, Izmir, Turkey
[2] Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst, Izmir, Turkey
[3] Izmir Democracy Univ, Vocat Sch Hlth Serv, Dept Healthcare Serv, Izmir, Turkey
[4] Dokuz Eylul Univ, Hlth Sci Inst, Dept Neurosci, Izmir, Turkey
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
关键词
dimethyl fumarate (DMF); microglia; NLRP3; inflammasome; lipopolysaccharide (LPS); sickness behaviors; pyroptosis; NF-KAPPA-B; PLACEBO-CONTROLLED PHASE-3; ORAL BG-12; NRF2; RECOGNITION; CYTOKINE; NEURONS; INNATE; SENSOR;
D O I
10.3389/fimmu.2021.737065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NLRP3 inflammasome activation contributes to several pathogenic conditions, including lipopolysaccharide (LPS)-induced sickness behavior characterized by reduced mobility and depressive behaviors. Dimethyl fumarate (DMF) is an immunomodulatory and anti-oxidative molecule commonly used for the symptomatic treatment of multiple sclerosis and psoriasis. In this study, we investigated the potential use of DMF against microglial NLRP3 inflammasome activation both in vitro and in vivo. For in vitro studies, LPS- and ATP-stimulated N9 microglial cells were used to induce NLRP3 inflammasome activation. DMF's effects on inflammasome markers, pyroptotic cell death, ROS formation, and Nrf2/NF-kappa B pathways were assessed. For in vivo studies, 12-14 weeks-old male BALB/c mice were treated with LPS, DMF + LPS and ML385 + DMF + LPS. Behavioral tests including open field, forced swim test, and tail suspension test were carried out to see changes in lipopolysaccharide-induced sickness behavior. Furthermore, NLRP3 and Caspase-1 expression in isolated microglia were determined by immunostaining. Here we demonstrated that DMF ameliorated LPS and ATP-induced NLRP3 inflammasome activation by reducing IL-1 beta, IL-18, caspase-1, and NLRP3 levels, reactive oxygen species formation and damage, and inhibiting pyroptotic cell death in N9 murine microglia via Nrf2/NF-kappa B pathways. DMF also improved LPS-induced sickness behavior in male mice and decreased caspase-1/NLRP3 levels via Nrf2 activation. Additionally, we showed that DMF pretreatment decreased miR-146a and miR-155 both in vivo and in vitro. Our results proved the effectiveness of DMF on the amelioration of microglial NLRP3 inflammasome activation. We anticipate that this study will provide the foundation consideration for further studies aiming to suppress NLRP3 inflammasome activation associated with in many diseases and a better understanding of its underlying mechanisms.
引用
收藏
页数:15
相关论文
共 57 条
  • [1] Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome
    Afonina, Inna S.
    Zhong, Zhenyu
    Karin, Michael
    Beyaert, Rudi
    [J]. NATURE IMMUNOLOGY, 2017, 18 (08) : 861 - 869
  • [2] Dimethyl fumarate ameliorates diabetes-associated vascular complications through ROS-TXNIP-NLRP3 inflammasome pathway
    Amin, Fatma M.
    Abdelaziz, Rania R.
    Hamed, Mohamed F.
    Nader, Manar A.
    Shehatou, George S. G.
    [J]. LIFE SCIENCES, 2020, 256
  • [3] Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway
    Arioz, Burak, I
    Tastan, Bora
    Tarakcioglu, Emre
    Tufekci, Kemal Ugur
    Olcum, Melis
    Ersoy, Nevin
    Bagriyanik, Alper
    Genc, Kursad
    Genc, Sermin
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [4] Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice
    Aubert, A
    Goodall, G
    Dantzer, R
    Gheusi, G
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 1997, 11 (02) : 107 - 118
  • [5] Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
    Bauernfeind, Franz G.
    Horvath, Gabor
    Stutz, Andrea
    Alnemri, Emad S.
    MacDonald, Kelly
    Speert, David
    Fernandes-Alnemri, Teresa
    Wu, Jianghong
    Monks, Brian G.
    Fitzgerald, Katherine A.
    Hornung, Veit
    Latz, Eicke
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (02) : 787 - 791
  • [6] Dimethyl Fumarate: A Review in Relapsing-Remitting MS
    Blair, Hannah A.
    [J]. DRUGS, 2019, 79 (18) : 1965 - 1976
  • [7] The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2
    Campolo, Michela
    Casili, Giovanna
    Biundo, Flavia
    Crupi, Rosalia
    Cordaro, Marika
    Cuzzocrea, Salvatore
    Esposito, Emanuela
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2017, 27 (08) : 453 - 471
  • [8] Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
    Cuadrado, Antonio
    Manda, Gina
    Hassan, Ahmed
    Jose Alcaraz, Maria
    Barbas, Coral
    Daiber, Andreas
    Ghezzi, Pietro
    Leon, Rafael
    Lopez, Manuela G.
    Oliva, Baldo
    Pajares, Marta
    Rojo, Ana I.
    Robledinos-Anton, Natalia
    Valverde, Angela M.
    Guney, Emre
    Schmidt, Harald H. H. W.
    [J]. PHARMACOLOGICAL REVIEWS, 2018, 70 (02) : 348 - 383
  • [9] Cytokine, Sickness Behavior, and Depression
    Dantzer, Robert
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2009, 29 (02) : 247 - +
  • [10] Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
    Diebold, Martin
    Sievers, Claudia
    Bantug, Glenn
    Sanderson, Nicholas
    Kappos, Ludwig
    Kuhle, Jens
    Lindberg, Raija L. P.
    Derfuss, Tobias
    [J]. JOURNAL OF AUTOIMMUNITY, 2018, 86 : 39 - 50